2012
DOI: 10.1016/j.cancergen.2012.05.005
|View full text |Cite
|
Sign up to set email alerts
|

Metallothionein 2A genetic polymorphisms and risk of prostate cancer in a Polish population

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

2
38
0

Year Published

2014
2014
2023
2023

Publication Types

Select...
5
1

Relationship

2
4

Authors

Journals

citations
Cited by 27 publications
(40 citation statements)
references
References 16 publications
2
38
0
Order By: Relevance
“…fresh or paraffin-embedded tumor samples, cell cultures, blood or plasma and the use of different cellular neoplasms models in vitro, which must have an impact on the final conclusions (Ahamed and Alhadlaq, 2014;Forma et al, 2012;Krześlak et al, 2013Krześlak et al, , 2014Pasha et al, 2008;Theocharis et al, 2011;Yaman, 2006;Yaman et al, 2007). It should be noted, however, that formalin-fixed and fresh tissues yielded virtually the same results for most of trace metals in human tissues and give more comparable and reliable data in comparison with other sample types.…”
Section: Discussionmentioning
confidence: 86%
See 4 more Smart Citations
“…fresh or paraffin-embedded tumor samples, cell cultures, blood or plasma and the use of different cellular neoplasms models in vitro, which must have an impact on the final conclusions (Ahamed and Alhadlaq, 2014;Forma et al, 2012;Krześlak et al, 2013Krześlak et al, , 2014Pasha et al, 2008;Theocharis et al, 2011;Yaman, 2006;Yaman et al, 2007). It should be noted, however, that formalin-fixed and fresh tissues yielded virtually the same results for most of trace metals in human tissues and give more comparable and reliable data in comparison with other sample types.…”
Section: Discussionmentioning
confidence: 86%
“…In conclusion, these studies imply that the presence of the G allele in the core promoter region of the MT2A gene may be an indicator of higher sensitivity for metal toxicity and carcinogenicity, as well as a useful potential marker for patients with increased risk of tumor (Forma et al, 2012;Kayaalti et al, 2010Kayaalti et al, , 2011Krześlak et al, 2013Krześlak et al, , 2014Seibold et al, 2011).…”
Section: Discussionmentioning
confidence: 94%
See 3 more Smart Citations